Paracoccidioides brasiliensis, the etiologic agent of paracoccidioidomycosis, causes disease much more frequently in men than it does in women, suggesting that the hormonal milieu of the host might influence P. brasiliensis pathogenicity. We Paracoccidioides brasiliensis, the etiologic agent of paracoccidioidomycosis, is indigenous to regions of South America. Although this organism causes disease 13 to 87 times more frequently in men than it does in women (3), the results of skin test studies indicate that contact with the pathogen is equal for the two sexes (8). Moreover, there is no sex-based difference in the disease rate of prepubertal individuals (7). This striking epidemiology led us to hypothesize that the hormonal environment of the host might directly affect P. brasiliensis and alter its pathogenicity. We reported the presence of a high-affinity, receptorlike binding protein for estradiol in cytosol from yeast cultures of P. brasiliensis (5). In addition, this binding protein was shown to be present in three additional clinical isolates (9). We presented evidence that estradiol can also regulate an important biological event in P. brasiliensis. Exposure of the fungus to physiologic concentrations of estradiol inhibited the transformation from the mycelial to the yeast form (5, 9), a critical event in the establishment of infection (10). We believe these experiments documented a possible molecular basis for the marked resistance of women to paracoccidioidomycosis.
Paracoccidioides brasiliensis, the etiologic agent of paracoccidioidomycosis, is indigenous to regions of South America. Although this organism causes disease 13 to 87 times more frequently in men than it does in women (3), the results of skin test studies indicate that contact with the pathogen is equal for the two sexes (8) . Moreover, there is no sex-based difference in the disease rate of prepubertal individuals (7) . This striking epidemiology led us to hypothesize that the hormonal environment of the host might directly affect P. brasiliensis and alter its pathogenicity. We reported the presence of a high-affinity, receptorlike binding protein for estradiol in cytosol from yeast cultures of P. brasiliensis (5) . In addition, this binding protein was shown to be present in three additional clinical isolates (9) . We presented evidence that estradiol can also regulate an important biological event in P. brasiliensis. Exposure of the fungus to physiologic concentrations of estradiol inhibited the transformation from the mycelial to the yeast form (5, 9) , a critical event in the establishment of infection (10) . We believe these experiments documented a possible molecular basis for the marked resistance of women to paracoccidioidomycosis.
In this paper, we describe the results of further experiments with the P. brasiliensis estrogen-binding protein. Because Mycelial cultures were grown by inoculating 200 ml of MVM medium plus 100 ml of yeast culture filtrate with small fragments of a 2-to 3-week-old MVM mycelial slant culture. Cultures were incubated at room temperature on a Gyrotory shaker (150 rpm) for 10 to 12 days. Mycelia were collected on filter paper, washed twice in saline and once in homogenization medium, and suspended in homogenization medium (50:50, vol/vol). Mycelial masses were then disrupted by six 15-s bursts with an electric grinding probe (Tissumizer; Tekmar Co., Cincinnati, Ohio), followed by vigorous agitation on a vortex mixer for 15 min with glass beads and cytosol preparation as described previously. Tubes were kept cold throughout the experiment by immersion in an ice slurry.
Binding studies. Steroid-binding assays were performed as previously described (5 of the high-affinity site is approximately twice as high in this study as it was in a previous study (5 , We believe that these differences reflect, at least in part, the more vigorous and time-consuming techniques required to prepare cytosol from mycelial-form P. brasiliensis. Our work with P. brasiliensis demonstrated that, to achieve optimal binding results, ice-cold conditions and rapid preparation of cytosol after initiation of cell disruption are required. In both cytosols, warming leads to destruction of the high-affinity binding site and to the appearance of the low-affinity binding site. We also detected large quantities of a low-affinity estrogen-binding site in mycelial cytosol (data not shown) similar to that found in yeast cytosol (Fig. 1) . A more significant difference in the estrogen-binding characteristics between mycelial and yeast cytosols was observed in competition experiments with unlabeled DES. DES has consistently been an extremely weak competitor for [3H]estradiol binding in yeast-form P. brasiliensis cytosol, as described in both previous reports (5, 9) and our current results. This was an unexpected finding, since DES did inhibit mycelial-to-yeast-form transformation, though generally with a 10-to 100-fold-lower potency than that of estradiol (5, 9) . The current finding, that the estrogenbinding site from mycelial cultures does have some affinity for DES, resolves in part the earlier discrepancies. In fact, the affinity of the mycelial estrogen-binding site for DES is about 1 to 2% of the value for estradiol, thus correlating better with the observed bioactivity of this compound relative to estradiol. We have not yet resolved whether the capacity of the mycelial estrogen-binding site to interact with DES is due to differences in the fungal cytosol milieu, which may affect binding, or a property of the binding moiety itself that is different from the yeast binding protein. It is also worth noting that tamoxifen had no effect on mycelial-toyeast transformation (9) and also had no measurable capability to displace [3H]estradiol from the estrogen-binding site obtained from either mycelial or yeast cytosol.
We believe that the current results support our hypothesis that the estrogen inhibition of the mycelial-to-yeast-form transition of P. brasiliensis is mediated by a cytosolic, high-affinity, estrogen-binding protein that is present in the mycelial form. This binding site differs from the mammalian estrogen receptor in its lower affinity for DES relative to estradiol (6) and in its inability to bind tamoxifen (4). These differences are consistent, however, with the bioactivity of DES and tamoxifen in the transformation experiments (5, 9) .
